Condition: Myasthaenia Gravis · Sponsor: Cartesian Therapeutics
The AURORA Study is evaluating the safety, tolerability, and efficacy of an investigational mRNA CAR T-cell therapy known as Descartes-08 in adults with acetylcholine receptor autoantibody -positive generalized myasthenia gravis. Part 1 of the study will last around 6 months. For eligible participants, Part 2 will last around 8 months.
This description comes directly from the study's public registry record.
Cartesian Clinical Trials · 617-231-8102 · trials@cartesiantx.com
Always discuss trial participation with your own doctor first.
| A40 | Tucson, Arizona, United States | Recruiting |
| A13 | Carlsbad, California, United States | Recruiting |
| A46 | Los Angeles, California, United States | Recruiting |
| A14 | Orange, California, United States | Recruiting |
| A21 | Aurora, Colorado, United States | Recruiting |
| A50 | Washington D.C., District of Columbia, United States | Recruiting |
| A48 | Maitland, Florida, United States | Recruiting |
| A10 | Tampa, Florida, United States | Recruiting |
| A53 | O'Fallon, Illinois, United States | Recruiting |
| A20 | Fairway, Kansas, United States | Recruiting |
| A16 | Lexington, Kentucky, United States | Recruiting |
| A38 | Boston, Massachusetts, United States | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06799247